Tenofovir gel for the prevention of herpes simplex virus type 2 infection.
dc.contributor.author | Abdool Karim, Salim Safurdeen. | |
dc.contributor.author | Abdool Karim, Quarraisha. | |
dc.contributor.author | Kharsany, Ayesha Bibi Mahomed. | |
dc.contributor.author | Baxter, Cheryl. | |
dc.contributor.author | Grobler, Anna Christina. | |
dc.contributor.author | Werner, Lise. | |
dc.contributor.author | Kashuba, Angela D. M. | |
dc.contributor.author | Mansoor, Leila Essop. | |
dc.contributor.author | Samsunder, Natasha. | |
dc.contributor.author | Mindel, Adrian. | |
dc.contributor.author | Gengiah, Tanuja Narayansamy. | |
dc.date.accessioned | 2016-11-12T07:11:02Z | |
dc.date.available | 2016-11-12T07:11:02Z | |
dc.date.created | 2015 | |
dc.date.issued | 2015 | |
dc.description | CAPRISA, 2015. | en_US |
dc.description.abstract | Abstract available in pdf. | en_US |
dc.identifier.citation | Abdool Karim, S.S., Abdool Karim, Q., Kharsany, A.B., Baxter, C., Grobler, A.C., Werner, L., Kashuba, A., Mansoor, L.E., Samsunder, N., Mindel, A. and Gengiah, T.N. 2015. Tenofovir gel for the prevention of herpes simplex virus type 2 infection. New England Journal of Medicine 373(6), 530-539. | en_US |
dc.identifier.uri | http://dx.doi.org/10.1056/NEJMoa1410649 | en_US |
dc.identifier.uri | http://hdl.handle.net/10413/13681 | |
dc.language.iso | en | en_US |
dc.publisher | Massachusetts Medical Society. | en_US |
dc.subject | Adenine/administration & dosage. | en_US |
dc.subject | Adenine/adverse effects. | en_US |
dc.subject | Adenine/analogs & derivatives. | en_US |
dc.subject | Administration, Intravaginal. | en_US |
dc.title | Tenofovir gel for the prevention of herpes simplex virus type 2 infection. | en_US |
dc.type | Peer reviewed journal article | en_US |